MPD: Data set: Donahue5

Procedures conducted:

• immune cell quantification

White blood cell and immune cell differentials.

Donahue5 downloads
• Download Donahue5 project data set animal data, as uploaded
• Download Donahue5 animal data matrix with factor-related expansion applied as necessary
• Download Donahue5 strain means, SD, N, etc. one row per strain/sex/measure

Ontology terms mapped to Donahue5 measures:

MA:0000059 blood
MP:0002458 abnormal B cell number
MP:0002602 abnormal eosinophil cell number
MP:0006387 abnormal T cell number
MP:0008043 abnormal NK cell number
MP:0008073 abnormal CD4-positive, alpha beta T cell number
MP:0008077 abnormal CD8-positive, alpha-beta T cell number
MP:0012440 abnormal neutrophil cell number
MP:0012441 abnormal monocyte cell number
VT:0000222 neutrophil quantity
VT:0000223 monocyte quantity
VT:0002458 B cell quantity
VT:0002602 eosinophil quantity
VT:0006387 T cell quantity
VT:0008043 natural killer cell quantity
VT:0008073 CD4-positive T cell quantity
VT:0008077 CD8-positive T cell quantity

Investigators	Leah Rae Donahue The Jackson Laboratory, Bar Harbor, ME
Participants	Morgan J
Contact	Leah Rae Donahue lrd@jax.org Lab web site
Affiliated Center	JAX Special Mouse Strains Resource
Acknowledgements	Funding provided by NIH RR016049, OD011102.
Project type	Phenotype strain survey data set
MPD identifiers	Donahue5 MPD:414
Data changelog	No updates/corrections. Initial release date: 10/2012.
Formatted citation	Click above to copy-paste the entire citation for this MPD web page.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)
Donahue5:1	Donahue5	immune cell quantification	(none)	neutrophil differential (percentage of viable WBC) [%] pct_NEUT 41401	B6.A consomic w/par	22	both	7wks	N=8

Donahue5:2	Donahue5	immune cell quantification	(none)	eosinophil differential (percentage of viable WBC) [%] pct_EOS 41402	B6.A consomic w/par	22	both	7wks	N=8

Donahue5:3	Donahue5	immune cell quantification	(none)	monocyte differential (percentage of viable WBC) [%] pct_MONO 41403	B6.A consomic w/par	22	both	7wks	N=8

Donahue5:4	Donahue5	immune cell quantification	(none)	inflammatory monocytes (percentage of viable WBC) [%] pct_MONO_inflam 41404	B6.A consomic w/par	22	both	7wks	N=8

Donahue5:5	Donahue5	immune cell quantification	(none)	resident monocytes (percentage of viable WBC) [%] pct_MONO_resident 41405	B6.A consomic w/par	22	both	7wks	N=8

Donahue5:6	Donahue5	immune cell quantification	(none)	B cells (percentage of viable WBC) [%] pct_B_cells 41406	B6.A consomic w/par	22	both	7wks	N=8

Donahue5:7	Donahue5	immune cell quantification	(none)	natural killer (NK) cells (percentage of viable WBC) [%] pct_NK_cells 41407	B6.A consomic w/par	22	both	7wks	N=8

Donahue5:8	Donahue5	immune cell quantification	(none)	mature natural killer (NK) cells (percentage of viable WBC) [%] pct_NK_mature 41408	B6.A consomic w/par	22	both	7wks	N=8

Donahue5:9	Donahue5	immune cell quantification	(none)	T cells (percentage of viable WBC) [%] pct_T_cells 41409	B6.A consomic w/par	22	both	7wks	N=8

Donahue5:10	Donahue5	immune cell quantification	(none)	CD4 T cells (percentage of viable WBC) [%] pct_CD4 41410	B6.A consomic w/par	22	both	7wks	N=8

Donahue5:12	Donahue5	immune cell quantification	(none)	CD8 T cells (percentage of viable WBC) [%] pct_CD8 41412	B6.A consomic w/par	22	both	7wks	N=8

Donahue5: Peripheral blood leukocytes in C57BL/6J-Chr#A/J/NaJ mouse chromosome substitution strains (2011)

Donahue5: Peripheral blood leukocytes in C57BL/6J-Chr#^A/J/NaJ mouse chromosome substitution strains (2011)